M&A Deal Summary |
|
|---|---|
| Date | 2017-01-01 |
| Target | Rautureau Apple Shoes |
| Sector | Apparel/Textiles |
| Buyer(s) | Naxicap Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2005 |
| PE ASSETS | 6.7B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Naxicap Partners is a private equity firm focused on leveraged buyouts and growth capital investments in small to medium-sized businesses in France, the Benelux, Spain, and Germany. Naxicap invests in a variety of sectors including business services, technology, healthcare, food, real estate, and consumer products. Naxicap Partners was established in 2005 and is headquartered in Paris, France.
| DEAL STATS | # |
|---|---|
| Overall | 94 of 139 |
| Sector: Apparel/Textiles M&A | 4 of 4 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 44 of 64 |
| Country: France M&A | 90 of 131 |
| Year: 2017 M&A | 5 of 14 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-01 |
HTL Biotechnology
Javene, France HTL Biotechnology is a fast-growing biotech and industrial firm leading the development and production of innovative pharmaceutical-grade biopolymers. The company has developed a state-of-the-art biopolymers platform that provides customized, pharmaceutical-grade biopolymer solutions to leading pharmaceutical and medical device companies worldwide. Its products are used in therapeutic areas such as ophthalmology, rheumatology, urology, dermatology, and medical aesthetics. HTL Biotechnology was formed in 1992 and is based in Javene, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-03-27 |
Eleven Paris
Paris, France Eleven Paris manufactures and markets apparel and accessories for men and women. Eleven Paris was founded in 2003 and is based in Paris, France. |
Sell | - |
